Genome-wide CRISPR screening reveals ADCK3 as a key regulator in sensitizing endometrial carcinoma cells to MPA therapy.

Authors:
Zhang Z; Zhang M; Zhou J; Wang D.

Journal:
Br J Cancer

Publication Year: 2023

DOI:
10.1038/s41416-023-02347-2

PMCID:
PMC10421920

PMID:
37402867

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Br J Cancer

Abbreviation: Br J Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of…
Young Han C; Bedia JS; Yang WL and 19 more (2024) - Transparency Score: 3/6
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and…
Su X; Jin K; Guo Q and 9 more (2024) - Transparency Score: 3/6
Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance…
Mah CY; Nguyen ADT; Niijima T and 12 more (2024) - Transparency Score: 4/6
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relaps…
Hogarty MD; Ziegler DS; Franson A and 15 more (2024) - Transparency Score: 3/6
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling i…
Mezquita L; Oulhen M; Aberlenc A and 9 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This research was supported by the National Key Technology Research and Developmental Program of China (Grant Nos. 2022YFC2704400 and 2022YFC2704402), the National Natural Science Foundation of China (Grant Nos. 82073132, 82122054, 82203340, 81872311 and 81502237), the CAMS Innovation Fund for Medical Sciences (Grant Nos. 2022-I2M-JB-003 and 2021-I2M-1-016), the Non-Profit Central Research Institute Fund of the Chinese Academy of Medical Sciences (Grant No. 2021-RC310-023) and the Overseas Expertise Introduction Center for Discipline Innovation (“111 Center”) (Grant No. BP0820029)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025